Trefoil peptides, E-cadherin, and β-catenin expression in sporadic fundic gland polyps: Further evidence toward the benign nature of these lesions

Applied Immunohistochemistry and Molecular Morphology

Volumn 17, Issue 5, 2009, Pages 431-437

  D'Odorico, Anna ^a,b   Cassaro, Mauro ^a   Grillo, Sabina ^a   Lazzari, Roberta ^a   Buda, Andrea ^a   Cardellini, Pietro ^a   Sturniolo Giacomo, Carlo ^a   Rugge, Massimo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

catenin; E cadherin; Fundic gland polyps; MIB1; Trefoil peptides

Indexed keywords

BETA CATENIN; KI 67 ANTIGEN; TREFOIL PEPTIDE; UVOMORULIN;

ARTICLE; ATROPHIC GASTRITIS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; FUNDIC GLAND POLYP; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STOMACH FUNDUS; STOMACH GLAND; STOMACH MUCOSA; STOMACH POLYP;

BETA CATENIN; CADHERINS; CELL ADHESION; CELL PROLIFERATION; HUMANS; IMMUNOHISTOCHEMISTRY; PEPTIDES; POLYPS; STOMACH;

EID: 70349744142     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181a03188     Document Type: Article

References (35)

1. Stolte M, Sticht T, Eidt S, et al. Frequency, location, and age and sex distribution of various types of gastric polyp. Endoscopy. 1994; 26:659-665. (Pubitemid 24361207)
2. Dickey W, Kenny BD, McConnell JB. Prevalence of fundic gland polyps in a Western European population. J Clin Gastroenterol. 1996;23:73-75. (Pubitemid 26244510)
3. Burt RW. Gastric fundic gland polyps. Gastroenterology. 2003;125: 1462-1469.
4. Marcial MA, Villafana M, Hernandez-Denton J, et al. Fundic gland polyps: prevalence and clinicopathologic features. Am J Gastroenterol. 1993;88:1711-1713. (Pubitemid 23298119)
5. Wei J, Chiriboga L, Yee H, et al. Altered cellular distribution of tuberin and glucocorticoid receptor in sporadic fundic gland polyps. Mod Pathol. 2002;15:862-869. (Pubitemid 34919779)
6. Miettinen M, Blay JY, Sobin LH, et al. WHO Classification of Tumours. Pathology and Genetics: Tumours of the Digestive Systems. Lyon, France: IARC Press; 2000:29, 58, 65,142-143.
7. Jalving M, Koornstra JJ, Boersma-van Ek W, et al. Dysplasia in fundic gland polyps is associated with b-catenin expression and relatively high cell turnover rates. Scand J Gastroenterol. 2003; 9:916-922. (Pubitemid 37153618)
8. Jalving M, Koornstra JJ, Gotz JM, et al. High-grade dysplasia in sporadic fundic gland polyps: a case report and review of the literature. Eur J Gastroenterol Hepatol. 2003;15:1229-1233. (Pubitemid 38174849)
9. Abraham SC, Park SJ, Mugartegui L, et al. Sporadic fundic gland polyps with epithelial dysplasia: evidence for preferential targeting for mutations in the adenomatous polyposis coli gene. Am J Pathol. 2002;161:1735-1742. (Pubitemid 35265531)
10. Kinoshita Y, Tojo M, Yano T, et al. Incidence of fundic gland polyps in patients without familial adenomatous polyposis. Gastrointest Endosc. 1993;39:161-163. (Pubitemid 23139708)
11. Machado JC, Nogueira ANMF, Carneiro F, et al. Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucines (MUC1, MUC2, MUC5AC, and MUC6). J Pathol. 2000; 190:437-444. (Pubitemid 30163583)
12. Hoffmann W. Trefoil factor family peptides: regulators of mucosal regeneration and repair, and more. Peptides. 2004;25:727-730. (Pubitemid 38721336)
13. Podolsky DK. Mechanism of regulatory peptide action in the gastrointestinal tract: trefoil peptide. J Gastroenterol. 2000;35 (suppl XII):69-74.
14. Thim L, Madsen F, Poulsen SS. Effect of trefoil factors on the viscoelastic properties of mucus gels. Eur J Clin Invest. 2002;32: 519-527. (Pubitemid 36223422)
15. Khan ZE, Wang TC, Cui G, et al. Transcriptional regulation of the human trefoil factor, TFF1, by gastrin. Gastroenterology. 2003;125: 510-521. (Pubitemid 36929433)
16. Taupin D, Wu DC, Jeon WK, et al. The trefoil gene family are coordinately expressed immediate-early genes: EGF receptor and MAP Kinase-dependent interregulation. J Clin Invest. 1999;103: R31-R38. (Pubitemid 29218307)
17. Nogueira AMMF, Machado JC, Carneiro F, et al. Patterns of expression of trefoil peptides and mucins in gastric polyps with and without malignant transformation. J Pathol. 1999;187:541-548. (Pubitemid 29151995)
18. Leung WK, Yu J, Chan FKL, et al. Expression of trefoil peptides (TFF1, TFF2 and TFF3) in gastric carcinomas, intestinal metaplasia, and non neoplastic gastric tissues. J Pathol. 2002;197: 582-588. (Pubitemid 34906554)
19. Kirikoshi H, Katoh M. Expression of TFF1, TFF2 and TFF3 in gastric cancer. Int J Oncol. 2002;21:655-659.
20. Buda A, Pignatelli M. Cytoskeletal network in colon cancer: from genes to clinical application. Int J Biochem Cell Biol. 2004;36: 759-765. (Pubitemid 38299390)
21. Wijnhoven BP, Pignatelli M. E-cadherin-catenin: more than a "sticky" molecular complex. Lancet. 1999;354:356-357.
22. Chan AO, Wong BC, Lan HY, et al. Deregulation of E-cadherin-catenin complex in precancerous lesions of gastric adenocarcinoma. J Gastroenterol Hepatol. 2003;8:534-539.
23. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 1991;251:1451-1455. (Pubitemid 121000430)
24. Abraham SC, Nobukawa B, Giardiello FM, et al. Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the b-catenin gene. Am J Pathol. 2001;158: 1005-1010. (Pubitemid 32221792)
25. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis: the updated Sydney system. International workshop on the histopathology of gastritis, Huston 1994. Am J Surg Pathol. 1996;20:1161-1181.
26. Lee RG, Burt R. The histopatology of fundic gland polyps of the stomach. Am J Clin Pathol. 1986;86:498-503. (Pubitemid 16006877)
27. Stolte M, Vieth M, Ebert MP. High-grade dysplasia in sporadic fundic gland polyps: clinically relevant or not? Eur J Gastroenterol Hepatol. 2003;15:1153-1156.
28. Hu GH, Yu BP, Dong WG, et al. Expression of 8TFF2 and helicobacter pylori infection in carcinogenesis of gastric mucosa. World J Gastroenterol. 2003;9:910-914. (Pubitemid 36686680)
29. Joo YE, Rew JS, Choi SK, et al. Expression of E-cadherin and catenins in early gastric cancer. J Clin Gastroenterol. 2002;35:35-42. (Pubitemid 34663348)
30. Song SY, Kim S, Kim DS, et al. Abnormal expression of E-cadherin in early gastric carcinoma: its relationship with macroscopic growth patterns and catenin alpha and beta. J Clin Gastroenterol. 2004; 38:252-259. (Pubitemid 38233334)
31. Hassan A, Yerian LM, Kuan SF, et al. Immunohistochemical evaluation of adenomatous polyposis coli, b-catenin, c-Myc, cyclin D1, p53 and retinoblastoma protein expression in syndromic and sporadic fundic gland polyps. Hum Pathol. 2004; 35:328-334. (Pubitemid 38339607)
32. Mitsufji S, Tsuchihashi Y, Kodama T. Histogenesis of hyperplastic polyps of the stomach in terms of cellular proliferation. J Gastroenterol. 1994;29:559-568. (Pubitemid 24308403)
33. Risio M, Arrigoni A, Pennazio M, et al. Mucosal cell proliferation in patients with hyperplastic colorectal polyps. Scand J Gastroenterol. 1995;30:344-348.
34. Yao T, Kajiwara M, Kuroiwa S, et al. Malignant transformation of gastric hyperplastic polyps: alteration of phenotypes, proliferative activity, and p53 expression. Hum Pathol. 2002;33:1016-1022. (Pubitemid 35215846)
35. Chen H, Wang LD, Guo M, et al. Alterations of p53 and PCNA in cancer and adjacent tissues from concurrent carcinomas of the esophagus and gastric cardia in the same patient in Linzhou, a high incidence area for esophageal cancer in northern China. World J Gastroenterol. 2003;9:16-21. (Pubitemid 36131270)